Boost for Europe's research plans
نویسنده
چکیده
After years of deliberation, the European Union introduced its new instrument of science funding, the European Research Council, through a back door, by including it in the latest edition of its Framework Program, FP7 (see Curr. Biol. (2005) 15, R359). Since then, a Scientific Council has been busy laying the foundations of what is designed to become a European pendant to the US National Science Foundation, and to provide project grants to researchers with minimal bureaucracy. Any fears that these worthy intentions might remain wishful thinking have been allayed with the recent announcement that Ernst-Ludwig Winnacker, one of the most experienced science managers in Europe, will be the ERC's first secretary-general. He is set to serve only half of the five-year tenure, to be replaced with the Spanish economist Andreu Mas-Colell in July 2009. Winnacker, a chemist who became one of the pioneers and godfathers of German molecular biology and biotechnology, is the founder and director of the Genzentrum at Munich, has served on the federal bioethics council, advised governments, and reached out to the general public. While his outspoken support for genetic engineering and biotechnology won him a few enemies in the 1980s, when even the production of human insulin by engineered bacteria was a highly controversial issue in Germany, his recent activities have mostly attracted praise from all sides. Most importantly, he has been the chief executive of the largest funding agency in Europe, Germany's Deutsche Forschungsgemeinschaft (DFG), since January 1998. The DFG, which also covers the whole spectrum of the sciences, commands an annual budget of over one billion euros, commensurate with that of Winnacker's new organisation. Winnacker had been elected for three consecutive terms at the top of the DFG, during which time he implemented a number of reforms without treading on too many toes. He had already announced that he would not seek re-appointment when his third term expires at the end of this year. Given Winnacker's relevant experience and the seamless transition from the end of his DFG position to the start of the European job, the ERC can look forward to a flying start. As the secretary-general, Winnacker will work with the scientific council, consisting of 22 scientists from across Europe, to ensure that the work can start smoothly. Researchers across Europe, whose grassroot campaigning for a simpler European funding process kicked off the development that created the ERC, will soon be able …
منابع مشابه
Dosimetric Evaluation of Target Volume in Breast Boost Radiotherapy: Comparison of Electron and Photon Beam
Background and purpose: Breast‑conserving surgery followed by radiation therapy to the whole breast is now recognized as a standard strategy in patients with breast cancer. Recommended technique for radiotherapy is whole breast irradiation followed by boost to the tumor bed. This study aimed to compare the dosimetric parameters of electron and photon beams for boosting irradiation in post‑lump...
متن کاملComparison of two radiation techniques in breast boost delivery
Introduction: In the treatment of breast cancer, breast conserving surgery (BCS) and whole breast irradiation is a usual technique. The influence of lumpectomy boost following breast radiotherapy is apparent, but there are different delivery methods. This work intended to compare the dosimetric parameters of electron beams and photon beams for boosting irradiation in breast can...
متن کاملEurope ramps up its research goals
But the Commission is now finalising the latest phase of its funding plans – Framework 6 – which will come into action later this year with radical plans to beef-up the scale and scope of its support of projects that can be seen to be fostering world-class collaborative research. Many universities may need to reassess the scale and scope of their research efforts if they are to win a share of t...
متن کاملIntensity Modulated Proton Therapy as a Boost Treatment after Prostate Seed Implant: A Treatment Planning Study
Purpose: Combination of Prostate Seed Implant (PSI) with External Beam Radiation Therapy (EBRT) remains as an attractive option for patients with intermediate or high-risk prostate cancer. One of the most widely used approaches is to use external beam radiation therapy (EBRT) to deliver boost doses after permanent prostate seed implant (PSI). In this study, the feasibility of using Intensity Mo...
متن کاملDosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer
PURPOSE The purpose of this study was to identify a more suitable boost plan for simultaneously integrated boost scheme in patients with breast cancer by comparing among 3 types of whole-breast irradiation plus tumor bed boost plans. METHODS Twenty patients who received radiotherapy following breast-conserving surgery for early breast cancer were enrolled in this study. We performed 1 type of...
متن کاملProstate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
BACKGROUND The delivery of a simultaneous integrated boost to the intra-prostatic tumour nodule may improve local control. The ability to deliver such treatments with hypofractionated SBRT was attempted using RapidArc (Varian Medical systems, Palo Alto, CA) and Multiplan (Accuray inc, Sunnyvale, CA). MATERIALS AND METHODS 15 patients with dominant prostate nodules had RapidArc and Multiplan p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Current Biology
دوره 16 شماره
صفحات -
تاریخ انتشار 2006